Cochrane Review Tranexamic acid for patients with nasal haemorrhage (epistaxis) https://t.co/PqTSYaw7Ek
@CarlaR_14 @Gregor_McIntosh @ParamedicsUK @RGUParamedics There is some evidence to support it, but it’s not compelling. https://t.co/8o8kSy1Gzv
@LIngram2207 @pabakz @SiButterworth Not a tranexamic acid nasal spray: - https://t.co/twmj4q73fD - https://t.co/19KHfPDXVE Practically, if you want topical, you'd think soaking cotton wool and sticking it up would be better than a drippy spray.
RT @WikiDocJames: 2x Take TXA for nosebleeds. Here we have a Cochrane review of a few small RCTs that found evidence of maybe benefit in 20…
2x Take TXA for nosebleeds. Here we have a Cochrane review of a few small RCTs that found evidence of maybe benefit in 2018... https://t.co/Fhy1EDsuGW
Tranexamic acid to help treat nosebleeds (epistaxis) https://t.co/qAiMJlyEnu. We used Nebulized TXA in our patient with a good result.
Acide tranexamique pour aider à traiter les saignements de nez (épistaxis) https://t.co/6trPMlDLon
Tranexamic acid for patients with nasal haemorrhage (epistaxis). - PubMed - NCBI https://t.co/gHfPPtRNed
RT @obrienek: @JenniferBrokaw @VenkBellamkonda @DrJenGunter There’s a Cochrane review on topical and oral TXA for epistaxis. Looks like TXA…
@JenniferBrokaw @VenkBellamkonda @DrJenGunter There’s a Cochrane review on topical and oral TXA for epistaxis. Looks like TXA is more effective than placebo; I’d prefer it over packing if possible. "Tranexamic acid for patients with nasal haemorrhage (epi
RT @CochraneENT: #CochraneEvidence Tranexamic acid for patients with #nosebleeds / #epistaxis https://t.co/1NZb598A8p
#CochraneEvidence Tranexamic acid for patients with #nosebleeds / #epistaxis https://t.co/1NZb598A8p
@DocteurAbbas @CHU4life @wargonm T’aimes pas mes iraniens ? Je te file de la @CochraneFrance https://t.co/3q0mdsONnk
@imccann1 @srrezaie I’ve seen the latest paper my Zahed et al, it’s included in the Cochrane https://t.co/EwI625bcUy. One study is not enough to change practice is it? It *probably* does work but don’t think a small unblinded study is enough yet...? Maybe
トラネキサム酸は鼻出血の再出血を減らすかもしれない。https://t.co/d7OtuDXKwt
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
Acide tranexamique pour aider à traiter les saignements de nez (épistaxis) https://t.co/J8rlG5ASZC
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexamic acid may reduce the risk of re‐bleeding https://t.co/l9jZu1Qsjm https://t.co/I1hjKf9SpS
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @keisyukeblog: 鼻血ブーに止血剤としてのトラネキサム酸の効果は微妙なのか。まぁ、そやな。 https://t.co/99Tq88LMn8
RT @keisyukeblog: 鼻血ブーに止血剤としてのトラネキサム酸の効果は微妙なのか。まぁ、そやな。 https://t.co/99Tq88LMn8
鼻血ブーに止血剤としてのトラネキサム酸の効果は微妙なのか。まぁ、そやな。 https://t.co/99Tq88LMn8
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @CochraneUK: Tranexamic acid to help treat nosebleeds (epistaxis). What does the Cochrane evidence from @CochraneENT say? Find out here:…
Good to hear. Also anecdotal evidence that forehead pressure and mopping dripping nose with tissue may increase risk of re-bleeding compared to direct pressure on bleeding site...
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
@LTHTHeadandNeck
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
RT @CochraneENT: New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (trane…
New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (tranexamic acid) may reduce the risk of re-bleeding: https://t.co/W5pwLpZpw2 https://t.co/Xy74fQ9BMQ
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
New evidence on the management of nosebleeds in patients presenting to hospital. A drug that assists blood clotting (tranexamic acid) may reduce the risk of re-bleeding: https://t.co/W5pwLpHOEu https://t.co/oG7UgHXW65
New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexamic acid may reduce the risk of re‐bleeding https://t.co/l9jZu1yQUM https://t.co/ODQY0CwWE3
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
Does tranexamic acid have a useful role in the management of patients with nosebleed (epistaxis)? A new review from @CochraneENT looks at this question: https://t.co/l9jZu1Qsjm https://t.co/RjDOXXGXxr
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
RT @TFujiwarbi: 鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる…
鼻血に対するトランサミン(経口・局所投与)のコクランレビュー。局所にしろ経口にしろ処置後再出血を3割ぐらい減らすみたい。 今の病院ではボスミン・キシロカインタンポンで止血が不安(再出血のエピソード、抗血小板剤使用等)な場合には局所使用も検討してる(適応外の諸手続きは必要)
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
RT @CochraneENT: New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexa…
New evidence on the management of nosebleed (epistaxis) from @CochraneENT: moderate‐quality evidence suggests that tranexamic acid may reduce the risk of re‐bleeding https://t.co/l9jZu1Qsjm
Does tranexamic acid (a drug that assists blood clotting) help to control bleeding in patients presenting to hospital with nosebleed (epistaxis)? A new review from @CochraneENT looks at this common condition: https://t.co/W5pwLpZpw2
What are the effects of tranexamic acid in the management of patients with nosebleed (epistaxis)? A new review from @CochraneENT looks at this question: https://t.co/l9jZu1Qsjm